Skip to content
BRFAA
BRFAA

Partners

BRFAA

Biomedical Research Foundation, Academy of Athens (BRFAA)

Coordinator of HTRI-EATRIS-GR network

BRFAA will provide access to infrastructures and expertise required for execution of Phase-I Trials, Bioequivalence studies, evaluation of new formulations of existing/established drugs, drug metabolism and pharmacokinetics studies (DMPK), Mass-Cytometry analysis (Cytof-Helios), Biochemical assays. Furthermore, BRFAA will provide access to a) established models relevant for preclinical evaluation of drugs, therapeutics in the areas of Cardiovascular, Respiratory, Metabolic, Neuro-degenerative and Inflammatory Diseases; b) State-of the-art Experimental Surgery operating-rooms and infrastructures to support evaluation of new devices in mice, rats, rabbits and pigs; c) Whole animal non-invasive imaging (Micro-Pet, Micro-Ultrasound and in the near future Micro-MRI) for in vivo preclinical evaluations; d) Toxicology studies in preclinical species (tolerability in rodents, mutagenicity tests, hematotoxicity, cardiac toxicity)